SLD
SALUDA MED CDI FORUS [SLD]
Healthcare · ASX Small Cap
$0.8000 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +11First seen: 2026-02-25
Score Breakdown
Technical54
Catalyst50
Sentiment50
Fundamental73
Momentum29
Risk Gate50
Get alerts when SLD's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Volume surging at 3.6x normal while price falls — heavy selling pressure
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Lagging the Small Ords index — relative strength of 0.86, underperforming its peers
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Adequate cash runway (5 quarters)
- Moderate revenue growth (+17%)
- Near 52-week low (1% of range)
- CANSLIM I: Institutional ownership (31%)
- Turned profitable (NPAT positive from results)
- Sentiment is mixed — no strong consensus either way
- Poor risk-adjusted returns — Sharpe of -2.0 means lots of volatility for not much reward
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Deeply negative margins (-214%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 25% over the past year
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.63%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about SLD
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Update - S&P DJI March 2026 Rebalance of the All Ordinaries
NONE S&P DJI Announces March 2026 Quarterly Rebalance
NONE H1 FY2026 Results Announcement
Recent ASX Announcements
| 2026-03-10 | Update - S&P DJI March 2026 Rebalance of the All Ordinaries PRICE SENSITIVE |
| 2026-03-06 | S&P DJI Announces March 2026 Quarterly Rebalance PRICE SENSITIVE |
| 2026-02-25 | H1 FY2026 Results Announcement PRICE SENSITIVE |
| 2026-02-25 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-16 | H1 FY26 Results Notification & Webinar |
Key Metrics
N/A
Market Cap
95K
Avg Volume
3.6x
Vol Ratio
$0.79 — $1.90
52-Week Range
0.0%
Short Interest
N/A
Cash Runway
N/A
ROE
-213.8%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | insufficient_data | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | insufficient_data | Float: 0% |
| L | Leader vs Laggard | laggard | RS: -10 |
| I | Institutional Sponsorship | pass | Inst: 30% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #52 of 117 · Sector avg: 46
View all Healthcare signals →Track SLD and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required